NeuroVive Pharmaceutical (Sweden) Profile

4.89
SEK 0.19  3.74%
85%
0%

NeuroVive Pharmaceutical Summary

NeuroVive Pharmaceutical AB (NVP) is traded on Stockholm Stock Exchange in Sweden. It is located in Medicon Village and employs 9 people. The company currently falls under 'Small-Cap' category with current market capitalization of 131.34 M. NeuroVive Pharmaceutical AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 52.33 M outstanding shares. NEUROVIVE PHARMA has accumulated about 15.76 M in cash with (57.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3.
Check NeuroVive Pharmaceutical Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 4.89HorizonTargetOdds Above 4.89
50.27%30 days 4.89 49.61%
Based on normal probability distribution, the odds of NeuroVive Pharmaceutical to move above current price in 30 days from now is about 49.61% (This NeuroVive Pharmaceutical AB probability density function shows the probability of NeuroVive Pharmaceutical Stock to fall within a particular range of prices over 30 days) .

NeuroVive Pharmaceutical Risk Profiles

Key Fundamentals

NeuroVive Pharmaceutical Against Markets

Current Ratings

NeuroVive Pharmaceutical 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
7 
Chance of
Financial Distress (0 to 100%)
74 
Equity ratings for NeuroVive Pharmaceutical AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
NeuroVive Pharmaceutical AB engages in the research and development of mitochondrial medicine in Sweden and internationally. NeuroVive Pharmaceutical AB was founded in 2000 and is headquartered in Lund, Sweden. NeuroVive Pharmaceutical operates under Drug Manufacturers - Major classification in Sweden and traded on Stockholm Stock Exchange. It employs 9 people. more
NameNeuroVive Pharmaceutical AB
Interim CEO and COOJan NilssonView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressMedicon Village
ExchangeStockholm Stock Exchange
ISINSE0002575340
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.neurovive.com
Phone46 4 62 75 62 20
CurrencySEK - Swedish Kronor

Directors

NeuroVive Pharmaceutical Corporate Directors
Please see also Stocks Correlation. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.